NCT02650505View on ClinicalTrials.gov

A Clinical Study to Evaluate the Sensitizing Potential of LEO 43204 Gel

PHASE1CompletedINTERVENTIONAL

Enrollment

233

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions

Actinic Keratosis

Interventions

DRUG

LEO 43204

DRUG

LEO 43204 Vehicle

Trial Locations (1)

07410

TKL Research Inc., Fair Lawn

Sponsors

Lead Sponsor

All Listed Sponsors

lead

LEO Pharma

INDUSTRY